Partnership to prevent HPV-related cervical cancer in women with HIV in Peru and the Dominican Republic
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
New ways to prevent HPV-related cervical cancer for women living with HIV in Peru and the Dominican Republic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11400874 on NIH RePORTER |
What this research studies
This partnership brings clinics in Peru and the Dominican Republic together with a coordinating center in Seattle to run three clinical trials focused on women living with HIV. The trials will test HPV vaccine dosing schedules and simpler, lower-cost screening and treatment approaches that can be delivered within routine HIV care. Blood and cervical samples will be sent to a central lab for testing and a statistics core will analyze results to find practical options for low-resource settings. The goal is to identify prevention approaches that clinics can realistically offer to reduce cervical cancer in women with HIV.
Who could benefit from this research
Good fit: Women living with HIV who are receiving care at participating clinics in Peru or the Dominican Republic and who are eligible for HPV vaccination or cervical screening.
Not a fit: People without HIV, men, or women who live outside the trial regions or who are not eligible for the trial are unlikely to be included or see direct benefit.
Why it matters
Potential benefit: Could identify vaccine schedules and screening/treatment methods that lower cervical cancer risk for women with HIV and are practical in low-resource clinics.
How similar studies have performed: HPV vaccines are proven to prevent cervical cancer in general populations, but optimal dosing and delivery for women living with HIV in low-resource settings are less well tested.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Madeleine, Margaret M — Fred Hutchinson Cancer Center
- Study coordinator: Madeleine, Margaret M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.